↓ Skip to main content

Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants

Overview of attention for article published in Cochrane database of systematic reviews, February 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

twitter
16 tweeters
facebook
1 Facebook page
wikipedia
1 Wikipedia page

Citations

dimensions_citation
116 Dimensions

Readers on

mendeley
145 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants
Published in
Cochrane database of systematic reviews, February 2015
DOI 10.1002/14651858.cd003481.pub6
Pubmed ID
Authors

Arne Ohlsson, Rajneesh Walia, Sachin S Shah

Abstract

Indomethacin is used as standard therapy to close a patent ductus arteriosus (PDA) but is associated with reduced blood flow to several organs. Ibuprofen, another cyclo-oxygenase inhibitor, may be as effective as indomethacin with fewer adverse effects.

Twitter Demographics

The data shown below were collected from the profiles of 16 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 145 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 1%
Norway 1 <1%
Ethiopia 1 <1%
South Africa 1 <1%
Netherlands 1 <1%
United States 1 <1%
Unknown 138 95%

Demographic breakdown

Readers by professional status Count As %
Student > Master 23 16%
Student > Postgraduate 19 13%
Student > Bachelor 16 11%
Student > Ph. D. Student 14 10%
Researcher 14 10%
Other 41 28%
Unknown 18 12%
Readers by discipline Count As %
Medicine and Dentistry 90 62%
Nursing and Health Professions 11 8%
Pharmacology, Toxicology and Pharmaceutical Science 4 3%
Biochemistry, Genetics and Molecular Biology 2 1%
Psychology 2 1%
Other 10 7%
Unknown 26 18%

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 April 2015.
All research outputs
#1,363,188
of 14,360,331 outputs
Outputs from Cochrane database of systematic reviews
#3,862
of 10,945 outputs
Outputs of similar age
#25,800
of 216,412 outputs
Outputs of similar age from Cochrane database of systematic reviews
#104
of 253 outputs
Altmetric has tracked 14,360,331 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,945 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.8. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 216,412 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 253 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.